SCHEMBL2654579

SCHEMBL2654579

COC(=O)CCNC(=O)c1ccc(CC(C)COc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 2/20 0.42
PPARG P37231 2/20 0.42
MAOB P27338 1/20 0.42
SPHK2 Q9NRA0 1/20 0.42
PPARA Q07869 3/20 0.42
MAPK14 Q16539 1/20 0.42
GCGR P47871 3/20 0.41
GIPR P48546 1/20 0.41
ADAMTS4 O75173 1/20 0.41
MMP13 P45452 1/20 0.41
ADCY6 O43306 1/20 0.41
ADCY3 O60266 1/20 0.41
ADCY9 O60503 1/20 0.41
ADCY5 O95622 1/20 0.41
ADCY8 P40145 1/20 0.41
ADCY7 P51828 1/20 0.41
ADCY2 Q08462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2653943 0.91 NR1H4 (0.48) MEN1KMT2AEPHX2GCGRADCY6
SCHEMBL2653550 0.91 GCGR (0.49) PPARDEPHX2PPARGPPARAMAPK14
SCHEMBL2662283 0.90 MEN1 (0.46) MEN1KMT2AMAOBSPHK2MAPK14
SCHEMBL2654679 0.89 PPARD (0.42) PPARDEPHX2PPARGPPARAGCGR
SCHEMBL2653911 0.84 GCGR (0.43) PPARDMEN1KMT2AEPHX2PPARG
SCHEMBL2653251 0.83 GCGR (0.37) PPARDEPHX2SPHK2PPARAGCGR
SCHEMBL2653962 0.83 MEN1 (0.58) MEN1KMT2AMAOBSPHK2MAPK14
SCHEMBL2272970 0.82 PPARG (0.47) PPARDEPHX2PPARGPPARAMAPK14
SCHEMBL2653428 0.82 GCGR (0.58) EPHX2GCGRGIPRADCY6ADCY3
SCHEMBL2653250 0.82 MEN1 (0.57) MEN1KMT2AMAOBSPHK2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed